Med-Chemist

Med-Chemist : "Quintessential Medicinal Chemistry"

Showing posts with label Reyvow (lasmiditan). Show all posts
Showing posts with label Reyvow (lasmiditan). Show all posts
Wednesday, March 11, 2020

FDA Approves Reyvow (lasmiditan), the First Serotonin (5-HT) 1F Receptor Agonist for the Acute Treatment for Migraine

›
Eli Lilly and Company (NYSE: LLY) announced today that the U.S. Food and Drug Administration (FDA) has approved  Reyvow  (lasmiditan) an...
›
Home
View web version

Contributors

  • Dr. Umesh..
  • https://www.med-chemist.com
Powered by Blogger.